Go to main content
logo unither pharmaceuticals site internet
  • 简体中文 | ZH-HANS
  • Français | FR
  • Português | PT-BR
  • Services
    • Manufacturing
      • Technology Transfer & Scale-Up
      • Commercial batches manufacturing
      • Small-batch manufacturing – rare diseases
      • Small-batch manufacturing – veterinary
    • Development
      • Formulation Development
      • Analytical Development
      • Clinical Batch & Placebo Manufacturing
      • Stability Studies
      • Ophthalmic Development
      • Co-Development Program
      • Regulatory Support
    • Out-licensing
      • Medical devices
      • Drugs
      • Product List
  • Solutions
    • By technology
      • Sterile liquids
      • Blow-Fill-Seal (BFS)
      • Multi-Dose
      • Non-sterile liquids
      • Stick-Pack
      • Spray
      • Bottle
      • Other
      • Solids & Semi-Solids
    • By therapeutic area
      • Ophthalmology
      • ENT
      • Injectable
      • Respiratory
      • Rare Diseases
      • Other Therapeutic Areas

    • Breakthrough Solutions
      • Euroject® – BFS Injectable
      • Carragelose – Viral Infection
      • Sol-Gel™ – Ophthalmology
      • Uniflash® – Oro-mucosal
    • Turnkey products
      • Medical devices
      • Drugs
      • Product List
  • The Group
    • About Us
      • About Us
      • Vision and Innovation
      • Executive Committee
      • History
    • Global presence
      • Overview
      • In France
      • In Brazil
      • In the United States
      • In China
    • Commitment
      • Cap 2030: our CSR strategy
      • Responsible Purchasing
    • News
      • News
      • Agenda
      • Press Area
  • Careers
    • Careers
      • Working at Unither
      • Our job opportunities
  • Inspire Hub
  • Contact
Site search
Press Enter to start the search
News
News

News

 Category filters

 Filter by categories:

 Select categories

 List of articles

Corporate

Construction of a New Industrial Facility in Gannat

Corporate News

Ophthalmics at Butantã site, São Paulo

Corporate

How Unither Pharmaceuticals fights the current COVID-19 outbreak

Corporate News

2020 Satisfaction Survey Results

Corporate

Blow-Fill-Seal (BFS) advanced aseptic process

Corporate News

Nanjing’s R&D cell inauguration

Corporate

Team captain of Unither Industries in Gannat

Corporate News

Laboratoire Unither Coutances inaugurates its new premises and production facilities

Corporate News

Jean-François Hilaire: newly appointed CEO of Unither Pharmaceuticals

Corporate News

Unither Pharmaceuticals has completed the purchase of the Novartis site located at Butantã, in São Paulo, Brazil.  

Corporate News

30 year anniversary

Corporate

From early stages of ophthalmic product development

1 2 Next >

Services

  • Manufacturing
  • Development
  • Out-licensing

Solutions

  • By technology
  • By therapeutic area
  • Breakthrough Solutions
  • Product notices

The group

  • About Us
  • Vision and Innovation
  • Executive Committee
  • History

Inspire Hub

Follow Us

  • X (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • YouTube (opens in a new tab)

Newsletter Signup

Newsletter
  • Legal links menu
  • Code of Conduct
  • Procurement Policy
  • Legal Notice
  • Privacy Policy
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.